Where the Science Is Headed Now The next phase of the GLP-1 story is less about format and more about stability in the body over time, a shift that became tangible in December 2025 when the FDA approved Novo Nordisks oral semaglutide (Wegovy), the first daily GLP-1 pill cleared for obesity treatment
Brain Res 592: 310316
I have noticed that Im sleeping much better but I have only noticed minimal changes to my appetite
When you take a standard glutathione capsule, the harsh acids in your stomach often break the molecule down into its three component amino acids before it ever reaches your bloodstream
New research from scientists at the University of Rochesters Wilmot Cancer Institute reveals that glutathionean antioxidant produced naturally in the body and widely marketed as a health supplementmay also serve as a powerful fuel source for cancer cells
It's like a breakthrough in another way is that here you have an ability to triumph over such a frustrating target, just like we've seen with Alzheimer's, of course, which may actually intersect with Alzheimer's, with a graveyard of failed drugs